|
Chennai:
Speciality pharmaceutical company, Sun Pharmaceutical
Industries, has declared a turnover Rs. 699.8 crore and
an after tax profit of Rs.191.2 crore for the nine month
period ended 31st December 2003. The respective figures
for the corresponding period in the previous year are
Rs.624.6 crore and Rs.191.2 crore.
For
the third quarter, the company''s profit after tax increased
by 26.1 per cent to Rs.70.4 crore and the turnover went
up by 13.5 per cent to Rs.247.3 crore as compared to the
previous year''s third quarter results.
The
company''s new 16 acre research and development campus
in Baroda, with a 200,000 sq ft research area, is nearing
completion and
will commence partial operations this year, while the
construction of the Mahakali R&D centre is progressing
on schedule
|
